The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zyprexa

10 milligram(s) Powder for solution for injection

Eli Lilly Nederland B.V.EU/1/96/022/016

Main Information

Trade NameZyprexa
Active SubstancesOlanzapine
Strength10 milligram(s)
Dosage FormPowder for solution for injection
Licence HolderEli Lilly Nederland B.V.
Licence NumberEU/1/96/022/016

Group Information

ATC CodeN05AH Diazepines, oxazepines, thiazepines and oxepines
N05AH03 olanzapine

Status

Authorised/WithdrawnAuthorised
Licence Issued02/07/2001
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back